{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:10:02Z","timestamp":1780686602311,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010226","name":"Department of Education of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijantimicag.2020.106216","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T18:06:05Z","timestamp":1604340365000},"page":"106216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1748-8084","authenticated-orcid":false,"given":"Guoming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsheng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weisheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueming","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjie","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106216_bib0001","unstructured":"WHO. Data from who.int\/emergencies\/diseases\/novel-coronavirus-2019. n.d."},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0002","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/M20-0504","article-title":"The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application","volume":"172","author":"Lauer","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0003","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.5.2000062","article-title":"Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20\u201328 January 2020","volume":"25","author":"Backer","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0004","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","article-title":"Treatment options for COVID-19: The reality and challenges","volume":"53","author":"Jean","year":"2020","journal-title":"J Microbiol Immunol Infec"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0005","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0006","first-page":"369","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0007","unstructured":"NIH. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-halts-clinical-trial-hydroxychloroquine. n.d."},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwaa113","article-title":"Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19","author":"Huang","year":"2020","journal-title":"Natl Sci Rev"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0010","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.18203\/2320-6012.ijrms20201957","article-title":"COVID-19, the novel coronavirus 2019: current updates and the future","volume":"8","author":"Singh","year":"2020","journal-title":"Int J Res Med Sci"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0011","first-page":"5","article-title":"COVID-19: learning from lessons to guide treatment and prevention interventions","author":"Triggle","year":"2020","journal-title":"Msphere"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0012","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pharmthera.2016.07.002","article-title":"Immune suppressive properties of artemisinin family drugs","volume":"166","author":"Hou","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0013","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2011.06.044","article-title":"Artemisinins and immune system","volume":"668","author":"Shakir","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0014","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11434-016-1105-z","article-title":"Immunomodulation of artemisinin and its derivatives","volume":"61","author":"Yao","year":"2016","journal-title":"Sci Bull"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","article-title":"Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin vitro\u201d replicative system","volume":"68","author":"Romero","year":"2005","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0016","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.bbrc.2006.07.014","article-title":"Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin","volume":"348","author":"Paeshuyse","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0017","doi-asserted-by":"crossref","first-page":"e81783","DOI":"10.1371\/journal.pone.0081783","article-title":"Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication","volume":"8","author":"Obeid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0018","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0960-894X(01)80266-3","article-title":"Synthesis and in vitro anti-human immunodeficiency virus activity of artemisinin (qinghaosu)-related trioxanes","volume":"4","author":"Jung","year":"1994","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0019","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","article-title":"Piperaquine","volume":"65","author":"Davis","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0021","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","article-title":"Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","volume":"77","author":"Dyall","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101673","article-title":"Detection and analysis of nucleic acid in various biological samples of COVID-19 patients","author":"Wu","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0024","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-020-06731-x","article-title":"Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China","author":"Pan","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0025","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12936-016-1134-8","article-title":"Population pharmacokinetic properties of artemisinin in healthy male Vietnamese volunteers","volume":"15","author":"Birgersson","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0026","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00228-005-0084-9","article-title":"Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects","volume":"62","author":"R\u00f6shammar","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/0037-8682-0453-2018","article-title":"Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients","volume":"52","author":"Wu","year":"2019","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0028","article-title":"Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial","author":"Hu","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0029","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.3390\/jcm9051583","article-title":"Herbal medicine for the treatment of coronavirus disease 2019 (Covid-19): a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Ang","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105126","article-title":"Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial","volume":"161","author":"Xiao","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges","author":"Lai","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0032","doi-asserted-by":"crossref","DOI":"10.35772\/ghm.2020.01054","article-title":"COVID-19 can suddenly become severe: a case series from Tokyo, Japan","author":"Nakamura","year":"2020","journal-title":"Global Health Med"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0033","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa020","article-title":"quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak","volume":"27","author":"Wilder-Smith","year":"2020","journal-title":"J Travel Med"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0034","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106216_bib0035","article-title":"Effect of artemisinin-piperaquine treatment on the electrocardiogram of malaria patients","volume":"52","author":"Wu","year":"2019","journal-title":"Rev Da Soc Bras Med Trop"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920304271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920304271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:39:11Z","timestamp":1760377151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920304271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0924857920304271"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106216","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of artemisinin-piperaquine for treatment of COVID-19: an open-label, non-randomised and controlled trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106216"}}